More than 1,000 eye care professionals worldwide have been using the AdaptDx® and AdaptDx Pro® to test for impaired dark adaptation, the earliest biomarker of age-related macular degeneration. Our customers tell the story of how they’re fighting against preventable blindness by identifying AMD at its earliest stages and closely monitoring its progression.
My team and patients love the AdaptDx Pro! Dark adaptation testing has never been easier with this breakthrough device. I recently brought on two new staff members who learned to use the AdaptDx Pro within one week and are already administering the test to patients with ease. This has been a major win for my practice!
I brought the AdaptDx into my practice in September 2018. Best. Decision. Ever. Detecting age-related macular degeneration at its earliest stage is the critical first step so I may intervene and get the best outcome for my patients. Things that we need to be homing in on to better prevent and treat both dry and wet AMD include hormones, oxidative stress, methylation, inflammation, nutrition, and genetics. My goal is to prevent vision loss from macular degeneration - BOTH dry and wet.
When I purchased my OCT, I must admit there was a learning curve reading the scans. With the AdaptDx, there is only the Rod Intercept to evaluate, so it was extremely easy to interpret and therefore incorporate into my practice.
The AdaptDx Pro was implemented as the standard of care in comprehensive eye care and proves vital in testing and monitoring our patients. Theia (the on-board technician) performs patient tests while technicians are free to assist other patients. This technology is so vital to the care we provide that another unit had to be purchased to accommodate our increased volume.
The AdaptDx Pro and Theia will change the future of AMD care because they make it easier for eye care professionals to test more patients and diagnose disease at an earlier stage.
The AdaptDx Pro is amazing for two primary reasons. One, the portability of it is phenomenal. The other piece that’s critical is that Theia, the onboard AI tech, provides the instructions for the test, so patients get consistent instructions every time.
By being able to test more patients, we’ll ultimately uncover more macular degeneration. That’s good for patients. And I think we all need to realize that what’s good for our patients winds up being good for our practices.
Screening for macular degeneration is important because as we know, once we lose sight in our macula and once it becomes affected, there’s no getting that back. So being proactive is a lot better than being reactive.
Primary eye care conquered glaucoma because they use technology that enabled them to accurately diagnose and monitor the disease.
Sometimes when you’re working in your own practice it’s like being in a vacuum and you have no idea what’s going on in the outside world. The AMD Excellence Program introduced me to best practices from across the country to help me improve my ability to capture and manage all the AMD in my practice.